But when the researchers analyzed the data, they found that fluoxetine appeared not to provide meaningful benefits for ...
Postpartum depression descended on Kristina Leos like a heavy fog that separated her from everyone she loved. She could see ...
Knowable Magazine reports on a new blood test, myLuma, predicting postpartum depression risk with over 80% accuracy, aiding ...
Similarly, in a warning about compounded finasteride, the United States Food and Drug Administration stated in April 2025 ...
Major depressive disorder (MDD) is characterized by a lowered mood and loss of interest, contributing not only to ...
Despite the advice of two of the most successful pop anthems of the last two decades, when it comes to depression, no one can ...
Treatment takes about 20 minutes, with the majority focusing on the left side of the brain to help with depression and a few ...
The FDA has granted 510(k) clearance and a label expansion for a transcranial magnetic stimulation device to treat patients ...
The FDA has cleared BrainsWay’s Deep Transcranial Magnetic Stimulation system for use as an adjunct therapy in adolescents with major depressive disorder.
Moment of Clarity has published a new educational article titled “Spravato for Bipolar Depression Treatment“, providing an in ...
PYC Therapeutics (ASX:PYC) has announced encouraging progress with its investigational drug VP-001, designed to treat Retinitis Pigmentosa type 11 (RP11), a severe genetic eye disorder. The company ...
Per the Drug Safety Monitoring Board (DSMB) meeting evaluating one-third of planned participants, study to continue as planned More than half of planned participants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback